Sign in to view Kip’s full profile
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
Sign in to view Kip’s full profile
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
Nashville, Tennessee, United States
Sign in to view Kip’s full profile
Kip can introduce you to 10+ people at Wellpath
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
891 followers
500+ connections
Sign in to view Kip’s full profile
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
View mutual connections with Kip
Kip can introduce you to 10+ people at Wellpath
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
View mutual connections with Kip
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
Sign in to view Kip’s full profile
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
Activity
891 followers
-
Kip Hallman reposted thisKip Hallman reposted this***Warning: Sarcastic Cybersecurity*** A CISO walked into an empty conference room and wiped off the Guest network password from the middle of the white board. A week later, the CISO walked into that same conference room and removed the printed out pieces of paper with the guest network password laid out all over the room. A weekly later, the CISO walked into that same conference room and used scissors to take down the newly laminated guest network password on the front side of the podium. One week Later, the CISO walked into the conference room, pulled up a chair, put his feet on the table, and cracked a corona without a password in sight. The security guard saw this and asked him what he was doing. He answered "I am celebrating changing the guest password to "StopWritingThisPasswordDownPleaseOrI'llMakeItEvenLongerToType!" ***Warning: Sarcastic Cybersecurity***
-
Kip Hallman shared thisI've had the privilege of serving on the RLCIE Advisory Board from the start, and it's been exciting to be a small part of its growth from a gutsy student-founded startup to a focal point of student engagement at CMC. Talented, driven students and alumni who continue to amaze with what they do. Couldn't be more proud!Randall Lewis Center for Innovation and Entrepreneurship
Randall Lewis Center for Innovation and Entrepreneurship
1yKip Hallman shared this🚀 Empower the Next Generation of Innovators with RLCIE! 🌟 At the Randall Lewis Center for Innovation & Entrepreneurship (RLCIE), we equip students with the skills, mindset, and real-world experiences needed to thrive as visionary business leaders. Since our launch in 2018, we’ve grown rapidly, now impacting 300+ students annually through programs like the Fellows Program, Venture Capital Program, Claremont Accelerator, and more. But we can’t do it alone—we need YOU! 💡 How Can Alumni & Parents Engage? Whether you donate time, expertise, or resources, your involvement shapes futures: ✅ Mentor a student or host a networking session/workshop ✅ Guide a student-run group or become a client (Product Space, Graphite Group, Claremont Accelerator, etc.) ✅ Host company visits or hire interns (semester/summer roles) ✅ Advise prospective entrepreneurs and investors (Claremont Accelerator, the Venture Capital Program) ✅ Join our Advisory Board or Donate to sustain our growth and innovation 🔗 Explore our Engagement Deck attached below to see how your unique skills can bridge classroom learning and real-world impact. Together, we’re building a community where students don’t just learn entrepreneurship—they live it. Let’s ensure every aspiring innovator has the tools to launch, scale, and lead. 🌍 Ready to make a difference? Comment below, DM us (or Ron LaPierre, Xinyue Zhang & Haven Qin), or scan the QR codes to start your journey! 👉 Tag an alum or parent who’d love to get involved! Shout out to the amazing alumni and parents currently on the RLCIE Advisory Board, including Henry Albrecht, Alex Bentley, Karl Bracken, Richard Chino, Sarah Chung, Ken DeJarnette, Adele English, Phillip Friedman, Kip Hallman, Jeffrey Hausman, Scott Kosch, Sarah Lewis, Suzi McBride, Charlie Montgomery, Drew Oetting, Barbara Rogan Brittany Ruiz, Mark Schwartz, Valay Shah, Dave Spencer, Ankit Sud, Kevin Tan, Dustin Lind, Ryan Bellissimo, and Will Richardson! #Innovation #Entrepreneurship #Mentorship #PayItForward #AlumniEngagement #FutureLeaders -
Kip Hallman shared thisHuge props to Shawn Valenta, driver of innovative Wellpath Healthcare Cloud...a game changer featured in HCIT News! We are bringing ER providers TO the sites we serve, saving lives and time thousands of times each month. Amazing stuff!Kip Hallman shared this“Wellpath used the telehealth framework to create and scale an emergency medicine telehealth service to local government county jails and state prisons across the country.”How a medical university's Telehealth Service Implementation Model can help youHow a medical university's Telehealth Service Implementation Model can help you
-
Kip Hallman shared thisKip Hallman shared thisIn honor of National Correctional Officers Week, we just want all of our amazing partners to know how we feel about them. https://lnkd.in/gB7pn8x #correctionalofficersweek
-
Kip Hallman shared thisBig Shout Out to the Front-Line Heroes at Wellpath and to all the Front-Line Healthcare Heroes...YOU ROCK!Kip Hallman shared thisTo all our heroes on the front lines - we see you, we hear you, and we appreciate you more than you will ever know. #frontlines #ourheroes #weappreciateyou #thankyou
-
Kip Hallman shared thisCouldn’t be more excited about working shoulder to shoulder with Patrick Kennedy to bring hope and healing to those who need it most! #mentalhealth #addictionrecoveryKip Hallman shared thishttps://lnkd.in/e9-z_cw
-
Kip Hallman shared thisI was lucky to have a chance to hear Kevin tell his powerful and moving story. I heartily recommend watching his TEDx talk. Kevin, I know our paths will cross many times.Kip Hallman shared thisWellpath leadership teams around the nation were given the unique opportunity to hear from keynote #TEDx speaker, Kevin Berthia. He shared the harrowing story that led him to become a global #suicideprevention advocate. 🖥️ Watch Kevin's powerful TEDx talk on our suicide prevention resource page: http://bit.ly/2ku4a7u #WeAreWellpath
-
Kip Hallman shared thisWellpath RN Zarina Yasin saved the lives of three patients in the Solana County Jail using Narcan, prompting Sheriff Tom Ferrara to award her with their Distinguished Service Medal. As Sheriff Ferrara told me, "this is a BIG deal!" Congratulations and thank you, Zarina...you rock!Kip Hallman shared thisCongratulations to Wellpath nurse Zarina Yasin for receiving the Distinguished Service Medal from Solano County Sheriff's Office! Visit our blog to read the full story behind this rare honor and Zarina's exemplary service. http://bit.ly/2lPjhZB #WeAreWellpathDistinguished Service Medal awarded to Wellpath nurse > WellpathDistinguished Service Medal awarded to Wellpath nurse > Wellpath
-
Kip Hallman shared thisA few small things we can all do to help reduce suicide.Kip Hallman shared thisToday is World Suicide Prevention Day. #WSPD serves as an important reminder that knowing the warning signs for suicide can help save lives. Watch this video to learn behaviors that may signal someone is at risk. #SuicidePrevention #WorldSuicidePreventionDay #WeAreWellpath
-
Kip Hallman liked thisKip Hallman liked thisI tested 7 of the newest consumer body-composition scales against DEXA. The results surprised me. This was an independent study with no industry funding or manufacturer involvement. I could not find another head-to-head comparison of these current models, so this gave us a chance to generate some genuinely new data. I partnered with Patrick at DexaSlim: https://dexaslim.com/. We recruited 19 volunteers, including men and women ages 22 to 66, with DEXA body-fat percentages ranging from 15.7% to 40.3%. Each participant completed a DEXA scan and then, during the same visit, completed measurements on the consumer scales. We used a predefined analysis, retained all readings in the dataset, excluded only prespecified flagged measurements from the primary analysis, and ran sensitivity analyses and paired statistical comparisons. The full participant-level data and statistical results are in the images. The biggest surprise was the $23 Etekcity. It was the simplest device we tested and the only one without hand electrodes, yet it finished just behind the top-ranked $479 Tanita RD-545. On average, Tanita was 10.0% off from DEXA and Etekcity was 13.6% off. Among participants measured by both devices, the difference in absolute error was small and not statistically significant. At the other end, the $599 Withings Body Scan was 26.4% off from DEXA, nearly twice the error of Etekcity. Hume was 42.1% off, more than 3 times the error of Etekcity and more than 4 times the error of Tanita. And all 7 scales underreported body-fat percentage relative to DEXA on average. Higher price, more hardware, and heavier marketing did not guarantee better agreement with DEXA. This is a small independent study, not the final word. But the results were consistent enough across our analyses to give me much more confidence in which devices performed well and which did not. And this is only half the story. Next week, I’ll share the second part of the study, where I looked at how these same scales performed at measuring muscle. So if you’re thinking about buying one, stay tuned. #Longevity #BodyComposition #DEXA #HealthTech #PreventiveMedicine #DigitalHealth #EvidenceBasedMedicine
-
Kip Hallman reacted on thisKip Hallman reacted on thisThis picture breaks my heart in a way I can’t fully explain. This was the last picture I ever received of my son, Jonathon. Look at him. He’s smiling. He’s holding his daughter. He looks okay. Less than a week later, he was gone. That is something I desperately want people to understand about veteran suicide: our veterans don’t always show us what they are going through. There isn’t always an obvious cry for help. There isn’t always a warning that makes everyone stop and realize something is terribly wrong. Sometimes there is a smile. Sometimes there is laughter. Sometimes there is a picture that looks completely ordinary. And sometimes, behind all of that, there is a battle we cannot see. I have looked at this picture countless times over the years, wondering what was behind that smile. What was he carrying that I couldn’t see? What did I miss? I can’t change what happened to Jonathon. But I can keep telling his story. That is why Jon’s Mission for 22 exists. We talk about veteran suicide because silence does not save lives. We remind veterans and their families to check in, to ask the uncomfortable questions, and to keep showing up, even when everything looks okay. Because sometimes the person smiling in the picture is the person fighting the hardest battle. Say his name. Jonathon. And please, check on your veterans. ❤️🇺🇸 #JonsMissionFor22 #VeteranSuicideAwareness #SayHisName #VeteransMentalHealth #YouAreNotAlone #EndTheSilence #MissionFor22
-
Kip Hallman reacted on thisKip Hallman reacted on thisGlad I got to play a small role in this. Super proud of the staff that made this happen.
-
Kip Hallman liked thisKip Hallman liked thisIt was a great pleasure to meet Professor Evelyne Bischof at the Human Longevity Clinic in Beijing. Evelyne is one of the world’s leading physicians in longevity and precision medicine. Her ability to combine rigorous science, advanced diagnostics, and deeply personalized clinical care represents the future of medicine. I have long admired her work, her leadership, and her commitment to transforming longevity medicine into an evidence-based medical discipline that can help people live longer and healthier lives. I am delighted that we share the same mission—and even more delighted to call her a friend and colleague in advancing the future of human longevity. #LongevityMedicine #PrecisionMedicine #HealthyLongevity #PreventiveMedicine #HumanLongevity
-
Kip Hallman reacted on thisThis is great advice. No matter what term the good guys come up with, the term will be co-opted and the profiteers will try to find workarounds. Thus, you need to have to dive into the details of contracts, map & score contract terms, etc. I'm grateful for the incredible folks contributing to the Nautilus Health Institute PBM Field Guide which includes detailed guidance on procurement methodology, model contract language (and tips for negotiation) and data use standards. Steve Ditto did a remarkable job of harnessing the best minds in the industry (if you are one of those and haven't participated yet, please join) into the Nautilus Contract X-Ray that will be released at RosettaFest later this month. They don't get better than the folks who've already volunteered their expertise (this will never be "done" so it's never too late to join). Alan Pannier, Pharm D,MBA Andrew McNerlin Anthony Pudlo Bryce Platt, PharmD Catalina Gorla David Mastrangelo MBA Dustin Conrad Erik Davis Jake Frenz Jen F. Joey Dizenhouse, FSA, MAAA John Rogers Jon Schlosser Levi Roseman Lisa Krajewski, MBA Logan Lyle Mark Mincy Michael Navin Pramod John Rachel Strauss Randy Vogenberg, PhD Sam Slaughter Scott Haas Sean M. Tim Thomas Traci Poole, Pharm.D., BCACP, BCGP, FAPhA Wes Hartig Zack Robinson, MBAKip Hallman reacted on thisYour PBM passes through 100% of rebates. Then it collects five other payments from drug manufacturers it never calls rebates, so the pass-through guarantee never touches them. This is the part most plan sponsors have never seen. The leak is not in the guarantee. It is in the definition of the word "rebate." A loose definition counts only the payment a manufacturer literally labels a rebate, which leaves four other categories of manufacturer money free to flow to the PBM under different names. These line items hide outside the rebate definition on most of them. Same manufacturer money, tied to your plan's drugs, sitting one defined word away from your report. Five payments your guarantee never touches: 1. Administrative / "admin reimbursement" fees. Manufacturer money for "program administration," defined as a service fee, not a rebate. 2. Price protection payments. Paid when a drug's list price rises. The rebate definition frequently does not count them. 3. Formulary placement / exclusivity payments. Money for a preferred slot. The clinical layer and the payment layer are rarely shown side by side. 4. Data and insights fees. Manufacturer payments for de-identified claims data on your members. Almost never inside the rebate definition. 5. GPO / rebate-aggregator service fees. The Federal Trade Commission documented the big-three PBMs' rebate-aggregating GPOs registered offshore: Ascent in Switzerland, Emisar in Ireland, Zinc. Fees can be taken at that layer before the pass-through to your plan even begins. Your contract still says 100%. 100% of whatever is left after the PBM paid itself first. Read your rebate definition, not your rebate guarantee. The gap between them is the money you never see. Save this before your next rebate-guarantee conversation. #PBMTransparency #Rebates #SelfFundedEmployers
-
Kip Hallman liked thisKip Hallman liked this2026 is being called the year of peptides. I want to be honest with you: it scares me. I’m not talking about insulin, glucagon, human growth hormone, GLP-1 agonists, even though those are all peptides. They are rigorously tested, FDA-approved, and prescribed by physicians with known safety profiles. What concerns me is a different category of peptides. A wave of compounds with limited animal data and even more limited human data, sold online as "for research use only," and increasingly injected by people who treat that label as a technicality rather than a warning. Here is the reality. If a product is not FDA-approved, nothing guarantees its sterility. Nothing guarantees what is actually in the vial. Anyone with a peptide synthesizer, which you can purchase, can manufacture and sell these compounds online. The barrier is chemistry knowledge and a credit card. I have seen what happens when this goes wrong. Two individuals required emergency care this year, one in an ICU, following an adverse reaction to an unapproved peptide at a meeting called RAADfest. The incident was not widely covered. But imagine if it had ended differently? Headlines like this set back serious science that could eventually help millions. We have people operating in this space who are acting irresponsibly. Prescribing, or more accurately selling, powerful compounds to people who are trusting them with their health. I am not cynical about longevity medicine. I believe this field will produce real, meaningful advances in human healthcare and longevity. But that outcome depends entirely on rigor, evidence, and the willingness to say clearly when something has not been proven safe. Before you inject anything that is not an approved drug, ask one question: What human safety and efficacy data exists for this specific compound, at this specific dose, from this specific source? If the answer is unclear, you have your answer. Follow me at Eric Verdin and the Buck Institute for Research on Aging evidence-grounded perspectives on what the science actually supports.
Experience & Education
-
Stealth Healthcare Venture
******* *** ***
-
********
***** ******
-
********* ******* ******* ****** *** ********** *** ****************
****** ** *** ***** ** ********
-
********* ******* *******
** undefined undefined
-
-
******* ***** **********
-
-
View Kip’s full experience
See their title, tenure and more.
Welcome back
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
New to LinkedIn? Join now
or
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
Licenses & Certifications
-
California CPA certification
-
Issued
Recommendations received
5 people have recommended Kip
Join now to viewView Kip’s full profile
-
See who you know in common
-
Get introduced
-
Contact Kip directly
Other similar profiles
-
Doug Klinger
Doug Klinger
Healthcare and technology investor, board director and CEO with 30 years of experience including board governance and general management of venture capital-backed, private equity-backed and public companies in healthcare, technology, financial services and retail sectors.
12K followersGreenwich, CT
Explore more posts
-
Kassandra Keller
JM Search • 2K followers
I’m pleased to share a new article, co-authored with my colleague Scott May, on how private equity firms are using Go-to-Market Centers of Excellence to drive portfolio growth. These COEs enable firms to align commercial strategy, streamline execution, and scale results across investments. https://lnkd.in/e_HPsYuc
41
2 Comments -
Stephen Phenneger
3K followers
AI is starting to make its way into advance care planning, as highlighted in Hospice News recently: http://bit.ly/3JjKNK0. Healthcare leaders need to be aware of both its potential and limits. AI can help teams identify patients earlier, ease documentation burdens and personalize outreach. Used wisely, it can give clinicians more time to focus on what matters most: meaningful conversations with patients and families. But technology can’t replace the human touch. We need strong guardrails around privacy, bias and transparency, plus clear clinician oversight. Any AI tool should support, not lead, the conversation. We must put ethics and equity at the center of piloting and adopting AI. The future of advance care planning should use AI to augment the human element rather than replacing it. #hospice #palliativecare #AI #advancecareplanning #healthcareinnovation #leadership
39
-
Kellee M. Johnson, M.A.
HCA Florida Sarasota Doctors… • 6K followers
@Provisors members nationwide, join us Tuesday morning for a healthcare M&A panel. A complex and consequential area when it comes to what's shaping deals today we'll dive into what most affects healthcare valuations and transactions in a market being pushed and pulled by payers, providers, policymakers, regulators, employers, pharmacy benefit managers, and a shifting economy. Is consolidation creating stronger systems, distorting the market, or simply becoming the price of strategy, survival, or negotiating power? Maybe all three? Panelists include: CJ Johnston, CMAP, CBB,CEPA, Eric Kintner Paul Siebrasse and Dillon Zwick. They promise a candid discussion about where buyers and sellers see opportunity, where the field is tilting, and what healthcare reveals about the larger pressures facing the U.S. economy. Register on the hub! Bill Richardson Benet Heames Kyle Malais Donald Curristan Emeka Ndukwe Kathy Watte Nichols Richard Y. Cheng, JD, CHC Phil Kim Cheryl Blazej Lebiecki Nishan de Silva Jonathan Mond Robin Siegel, Esq. Eric Frantsvog
4
2 Comments -
Nate Gagne
Empactful Studios • 1K followers
When I was an executive at Tufts Medicine's Clinically Integrated Network, this was the exact tension we lived in every quarter: running a primary care network that still had to bill fee-for-service to keep the lights on, while trying to build the infrastructure for value-based arrangements that were the actual future. Most vendors made you pick a side. That's what made this hard. Our team at Empactful recently published our latest Perspectives piece on primary care, and I think it gets at something real: with 58,000 fewer primary care physicians projected by 2040 and a fifth of the country turning 65+ by then, the practices left standing will be the ones that can do both — optimize today's fee-for-service billing and build the care-gap-closure, risk-stratification, and engagement muscle value-based care demands. Agentic AI is finally making that dual mandate operationally realistic instead of a slide in a strategy deck. One example we highlight is ThoroughCare, one of Empactful Capital's portfolio companies. I'll be honest — I wish we'd had something like it at Tufts. It sits right at the intersection I just described: it helps practices capture the FFS billing tied to care-management activities (CCM, TCM, RPM, APCM, ACCESS, etc.) that too often go undocumented and unbilled, while that same workflow is exactly what builds the patient activation and risk data you need to actually perform under value-based contracts. Same clinical activity, funding today's operations and building tomorrow's capability at once. That's a genuinely accretive model for a health system executive, not just a nice-to-have. The stat that stuck with me from the piece: continuous, well-coordinated diabetes management alone can save roughly $33K per patient per year. That's the kind of number that used to take a room full of consultants to get leadership to believe. Worth a read if you're building in this space, running a practice, or just trying to figure out where care delivery is headed next.
6
-
Julia Monfrini Peev
PACE Healthcare Capital • 7K followers
#JPM2026 was 𝒕𝒉𝒂𝒕 good. A few quick takeaways: • Still the single best place in healthcare to reconnect with 𝐞𝐯𝐞𝐫𝐲𝐨𝐧𝐞 𝐰𝐡𝐨 𝐚𝐜𝐭𝐮𝐚𝐥𝐥𝐲 𝐦𝐚𝐭𝐭𝐞𝐫𝐬. • Women’s health keeps accelerating: $100B+ in exits over the past 25 years. Not a niche. A category (Forbes link below). Credit to Women's Health Advocates and PEWIN - Private Equity Women Investor Network for relaying such important data. • Huge shoutout to Springboard Enterprises for consistently backing founders early; and to Accenture, Bank of America, Deloitte, and McKinsey & Company for great events. • AI is coming for everything. • And yet… 90,000 people still showed up in San Francisco to talk it through in person. Human intelligence remains very much alive. Much love for my fellow healthcare diehards - Umbreen Bhatti, Eve Blossom, Emily Counceller, Laura Daily, Frederique Dame, Ted Haack, Alyssa Jaffee, Kay Koplovitz, Kate "HK" Liebelt, Gloria Olivier, Sylvia Qiu, MD, MBA, Liz Powell, Cheryl Rucker-Whitaker MD, MPH and many more! And always good energy with the Bridge Funding Global team, Emna Ghariani and Amin Jallouli 💙 Women’s health exits > $100B: link in comments 👇
134
18 Comments -
Becker's Healthcare
411K followers
🎯 “As a CEO, I have three jobs — and when I came to Catholic healthcare, I added a fourth.” At Becker’s CEO + CFO Roundtable, Eduardo Conrado, President of Ascension, shared a concise yet powerful framework for modern healthcare leadership: 1️⃣ Lead strategy 2️⃣ Match capital to that strategy 3️⃣ Align and develop the right talent 4️⃣ And above all — stay mission-driven in every decision As the healthcare landscape shifts, his message underscores a timeless truth: purpose and performance must move in lockstep. 🎥 Watch Eduardo Conrado explain how aligning strategy, capital, and talent around mission is shaping the future of Ascension. #BeckersCEOCFO #HealthcareLeadership #MissionDriven #CLevelStrategy #AscensionHealth
424
12 Comments -
Alex Levental
Ironwood Capital • 12K followers
We’re excited to share our latest perspective on healthcare investing and opportunity within the lower middle market. As the healthcare landscape evolves, traditional provider-focused strategies are being reshaped by margin pressures and regulatory shifts. In this new environment, Ironwood Capital sees meaningful potential in non-provider healthcare sectors. From medical product manufacturing to tech-enabled services that offer durable business models and room for operational growth. In the blog, we explore why these often overlooked segments deserve attention from investors seeking sustainable growth in healthcare, and how we think about partnering with management teams to unlock value over the long term. We welcome your thoughts and discussion! #HealthcareInvesting #PrivateEquity #MiddleMarket #IronwoodCapital #InvestmentStrategy #PrivateCredit #HealthcareServices https://conta.cc/3OykwJW
55
2 Comments -
Jessica L. Moon, PhD
The Implementation Group • 2K followers
🍇 𝗚𝗿𝗮𝘁𝗲𝗳𝘂𝗹 (𝘎𝘳𝘢𝘱𝘦𝘧𝘶𝘭 😅) 𝗳𝗼𝗿 𝗮 𝘄𝗼𝗻𝗱𝗲𝗿𝗳𝘂𝗹 𝘄𝗲𝗲𝗸𝗲𝗻𝗱 𝗮𝘁 𝘁𝗵𝗲 𝗕𝗟𝗣𝗡 𝗡𝗮𝗽𝗮 𝗜𝗻𝘃𝗲𝘀𝘁𝗼𝗿 𝗦𝘂𝗺𝗺𝗶𝘁 I was honored to participate in the Non-Dilutive Funding panel alongside an exceptional group of leaders working across foundations, consortia, government programs, and venture—Jill Sorensen (MTEC | Medical Technology Enterprise Consortium), Holly Burkman (BIO Alabama), Sean Drake (Stony Lonesome Group LLC), Eric H. Hanson MD, MPH (MILMED Connect), Greg Grinberg (Origin Foundation Inc). A few takeaways that really stood out 👇🏼 🔹 𝗡𝗼𝗻-𝗱𝗶𝗹𝘂𝘁𝗶𝘃𝗲 𝗰𝗮𝗽𝗶𝘁𝗮𝗹 𝗶𝘀 𝗮𝗯𝗼𝘂𝘁 𝗮𝗹𝗶𝗴𝗻𝗺𝗲𝗻𝘁, 𝗻𝗼𝘁 𝗼𝗽𝗽𝗼𝗿𝘁𝘂𝗻𝗶𝘀𝗺 The strongest programs reward teams that understand who the sponsor is, what problem they’re solving, and how the work translates to real-world impact — not those chasing every open RFP. 🔹 𝗧𝗵𝗲 𝘃𝗮𝗹𝘂𝗲 𝗶𝘀𝗻’𝘁 𝗷𝘂𝘀𝘁 𝘁𝗵𝗲 𝗱𝗼𝗹𝗹𝗮𝗿𝘀 When integrated thoughtfully, non-dilutive funding can: • De-risk early development • Extend runway by 12–18+ months • Unlock sole-source or follow-on opportunities • Strengthen downstream equity raises 🔹 𝗚𝗿𝗮𝗻𝘁 𝗳𝘂𝗻𝗱𝗶𝗻𝗴 𝗮𝗻𝗱 𝗩𝗖 𝗰𝗮𝗽𝗶𝘁𝗮𝗹 𝗮𝗿𝗲 𝗶𝗻𝗰𝗿𝗲𝗮𝘀𝗶𝗻𝗴𝗹𝘆 𝗰𝗼𝗺𝗽𝗹𝗲𝗺𝗲𝗻𝘁𝗮𝗿𝘆 — 𝗻𝗼𝘁 𝗰𝗼𝗺𝗽𝗲𝘁𝗶𝘁𝗶𝘃𝗲 From an investor perspective, non-dilutive funding can meaningfully de-risk technical and regulatory milestones, allowing VC dollars to go further and be deployed more strategically. We’re seeing more funds intentionally use blended capital stacks — combining grants, consortia funding, and equity — to extend runway, improve capital efficiency, and ultimately increase impact. 🔹 𝗙𝗲𝗱𝗲𝗿𝗮𝗹 𝗳𝘂𝗻𝗱𝗲𝗿𝘀 𝗹𝗶𝗸𝗲 𝗡𝗜𝗛 𝗮𝗻𝗱 𝗡𝗦𝗙 𝗮𝗻𝗰𝗵𝗼𝗿 𝗹𝗼𝗻𝗴-𝘁𝗲𝗿𝗺 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 While timelines can be longer, they remain essential drivers of biomedical progress. NSF funds significant biomedical and translational work across engineering, computation, and health that 𝘤𝘰𝘮𝘱𝘭𝘦𝘮𝘦𝘯𝘵𝘴 NIH funding—often earlier than private capital can engage. 🔹 𝗢𝗧𝗔𝘀 𝗮𝗻𝗱 𝗰𝗼𝗻𝘀𝗼𝗿𝘁𝗶𝗮 𝗰𝗵𝗮𝗻𝗴𝗲 𝘁𝗵𝗲 𝘀𝗽𝗲𝗲𝗱 𝗲𝗾𝘂𝗮𝘁𝗶𝗼𝗻 Models like MTEC's OTAs demonstrate how companies can move faster than traditional grant pathways and use them to open doors to new opportunities. 𝘛𝘩𝘦 𝘯𝘢𝘮𝘦 𝘰𝘧 𝘵𝘩𝘦 𝘨𝘢𝘮𝘦 𝘪𝘴 𝘱𝘳𝘦𝘱𝘢𝘳𝘢𝘵𝘪𝘰𝘯. HUGE thanks to ✨ Christiaan Engstrom and Caley Anderson, MBA ✨at BLPN for putting this panel together and for recognizing non-dilutive funding as a critical topic in today’s capital-constrained environment. #NonDilutiveFunding #LifeSciences #CapitalStrategy #BLPN #SBIR #OTA #MedTech #Biotech
35
3 Comments
Explore top content on LinkedIn
Find curated posts and insights for relevant topics all in one place.
View top content